West Pharmaceutical Services Cash flow hedges increased by 35.3% to -$1.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 164.7%, from $1.70M to -$1.10M.
Fluctuations indicate the effectiveness of the company's hedging strategy in managing market volatility and protecting future cash flows.
This metric tracks the gains or losses recognized in other comprehensive income resulting from the effective portion of...
Standardized reporting for companies utilizing derivatives to manage financial risk exposure.
other_other_comprehensive_income_loss_cash_flow_hedge_ga_aa440c| Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | -$2.00M | -$2.80M | -$3.70M | $5.50M | $1.70M | $2.20M | -$1.70M | -$1.10M |
| QoQ Change | — | -40.0% | -32.1% | +248.6% | -69.1% | +29.4% | -177.3% | +35.3% |
| YoY Change | — | — | — | +375.0% | +160.7% | +159.5% | -130.9% | -164.7% |